Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.
Market Dynamics
The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.
Key features of the study
- This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
- Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.
Market Segmentation
- By Product Type
- Human Chorionic Gonadotropin
- Recombinant Human Chorionic Gonadotropin
- By Therapeutic Application
- Male Hypogonadism
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Chronic Pain
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- North America
- Key Players Insights
- Merck & Co., Inc.
- Ferring B.V.
- Fresenius SE & Co.KGaA,
- Lupin
- Sun Pharmaceutical Industries Ltd.
- Lee BioSolutions
- Serum Institute of India Pvt. Ltd.
- Scripps Laboratories
- Sanzyme Biologics Pvt. Ltd.
- VHB Medi Sciences Limited Bharat Serums
- Vaccines Limited (BSV)
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.
Table of Contents
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Therapeutic Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER’s Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Human Chorionic Gonadotropin
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Recombinant Human Chorionic Gonadotropin
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Male Hypogonadism
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Female Infertility Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Oligospermic Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Cryptorchidism Treatment
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Chronic Pain
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2026-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Merck & Co., Inc.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Ferring B.V.,Fresenius SE & Co.KGaA
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Lupin
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Lee BioSolutions
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Serum Institute of India Pvt. Ltd
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Scripps Laboratories
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Sanzyme Biologics Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV)
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Zydus Lifesciences Ltd
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
- Corona Remedies Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Recent Developments/Updates
Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
Section
- References
- Research Methodology
- About Us and Sales Contact
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients


